Barclays »

Fulcrum Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $460k 68k 6.75
2023-06-30 $478k 145k 3.30
2023-03-31 $77k 27k 2.84
2022-12-31 $85k 12k 7.27
2022-09-30 $12k 1.4k 8.29
2022-06-30 $8.0k 1.7k 4.67
2022-03-31 $554k 23k 23.69